Pihlajalinna OyjFRA:38P -0.39%72 ROE % is 18.87% as of Mar. 2026, which is 125% above its 10-year median of 8.38. GuruFocus rates FRA:38P with a GF Score™ of 72/100 and a GF Value™ of €8.89 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 628 Healthcare Providers & Services companies, Pihlajalinna Oyj ranks better than 83.92% on this metric.
The historical rank and industry rank for Pihlajalinna Oyj's ROE % or its related term are showing as below:
FRA:38P'
s ROE % Range Over the Past 10 Years
Min: 3.03 Med: 8.38 Max: 20.81
Current: 19.49
During the past 13 years, Pihlajalinna Oyj's highest ROE % was 20.81%. The lowest was 3.03%. And the median was 8.38%.
FRA:38P's ROE % is ranked better than 83.92% of 628
companies
in the Healthcare Providers & Services industry
Industry Median: 5.72
vs FRA:38P: 19.49
Pihlajalinna Oyj (FRA:38P) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Pihlajalinna Oyj ROE % Related Terms
Pihlajalinna Oyj ROE % Historical Data
* Premium members only.
The historical data trend for Pihlajalinna Oyj's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Pihlajalinna Oyj's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pihlajalinna Oyj ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pihlajalinna Oyj's ROE % distribution charts can be found below:
* The bar in red indicates where Pihlajalinna Oyj's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Pihlajalinna Oyj (FRA:38P) has a ROE % of 18.87% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Pihlajalinna Oyj and its competitors. This is 125% above median its historical median of 8.38. Over the past decade, Pihlajalinna Oyj's ROE % has ranged from 3.03 to 20.81. According to the industry distribution chart, Pihlajalinna Oyj ranks #101 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 16.1%.
Is Pihlajalinna Oyj's ROE % too high?
Pihlajalinna Oyj's current ROE % of 18.87% is 125% above median its 10-year median of 8.38. Over the past 10 years, this metric has ranged from a low of 3.03 to a high of 20.81. The Healthcare Providers & Services industry median ROE % is 5.72. Pihlajalinna Oyj's value of 18.87% is 229.9% above this industry median. Based on the distribution chart, Pihlajalinna Oyj ranks #101 out of 628 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pihlajalinna Oyj has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pihlajalinna Oyj's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pihlajalinna Oyj ranks #101 out of 628 companies for ROE %. This places Pihlajalinna Oyj in the top 16% of its industry — outperforming the majority of peers. The industry median ROE % is 5.72. Pihlajalinna Oyj's value of 18.87% is 229.9% above this benchmark. Historically, Pihlajalinna Oyj's own ROE % has ranged from 3.03 to 20.81 over the past decade. While the company's 10-year median is 8.38 vs. the industry median of 5.72, Pihlajalinna Oyj has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pihlajalinna Oyj's current ROE % of 18.87% is 229.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Pihlajalinna Oyj and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pihlajalinna Oyj's current ROE % is 18.87%, which is 125% above median its own 10-year median of 8.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pihlajalinna Oyj stock overvalued right now?
Based on GuruFocus' analysis, Pihlajalinna Oyj (FRA:38P) is currently considered Modestly Overvalued. The stock's GF Value™ is €8.89, compared to a current price of €10.26 — trading 15.4% above its estimated fair value. The current ROE % is 18.87%, which is 125% above median its 10-year median of 8.38 and 229.9% above the Healthcare Providers & Services industry median of 5.72. Pihlajalinna Oyj's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Pihlajalinna Oyj (FRA:38P), the current ROE % is 18.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pihlajalinna Oyj (FRA:38P) Overvalued in 2026?
Based on GuruFocus' analysis, Pihlajalinna Oyj stock appears to be overvalued.
The current stock price of €10.26 is trading 15.4% above its estimated GF Value™ of €8.89.
GuruFocus considers Pihlajalinna Oyj to be Modestly Overvalued.
Key valuation signals for FRA:38P:
ROE %: 18.87% (125% above median its 10-year median of 8.38)
GF Value™: €8.89 vs. price of €10.26 (15.4% above fair value)
Industry Position: 229.9% above the Healthcare Providers & Services median (#101 of 628)
No single metric tells the full story. See the FRA:38P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pihlajalinna Oyj is a private social and healthcare service providers in Finland. It provides comprehensive, high-quality services through private clinics, hospitals, remote channels, occupational healthcare, and tailored social and healthcare solutions for the public sector. It has two reportable segments: Private Healthcare Services and Public Services. The Private Healthcare Services operating segment consists of private clinic, diagnostics, hospital, occupational healthcare, remote and fitness center services. The Public Services operating segment consists of social and healthcare services produced for the public sector, which include outsourcing and housing services, mainly remotely produced responsible doctor services, as well as a wide range of staffing and recruitment services.
72GF Score
Get the complete analysis for FRA:38P
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:38P has been successfully added to your 
